These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32543142)

  • 81. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma.
    Esmeray Sönmez E; Hatipoğlu T; Kurşun D; Hu X; Akman B; Yuan H; Erşen Danyeli A; Alacacıoğlu İ; Özkal S; Olgun A; Erdağ TK; You H; Küçük C
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359790
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.
    Carvajal-Cuenca A; Sua LF; Silva NM; Pittaluga S; Royo C; Song JY; Sargent RL; Espinet B; Climent F; Jacobs SA; Delabie J; Naresh KN; Bagg A; Brousset P; Warnke RA; Serrano S; Harris NL; Swerdlow SH; Jaffe ES; Campo E
    Haematologica; 2012 Feb; 97(2):270-8. PubMed ID: 22058203
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Sensitive quantification of the intronless SOX11 mRNA from lymph nodes biopsies in mantle cell lymphoma.
    Nielsen PI; Hansen SV; Møller MB; Kristensen TK; Cédile O; Hansen MC; Ebbesen LH; Haaber J; Abildgaard N; Nyvold CG
    Leuk Res; 2019 Mar; 78():1-2. PubMed ID: 30640013
    [No Abstract]   [Full Text] [Related]  

  • 85. Mantle Cell Lymphoma With Mantle Zone Growth Pattern.
    Yuan J; Li S; Liu X; Su RJ; Chen M; Wu X; Zheng G; Smith LM; Wang L; Li Y; Liu C; Zhou J; Shen Q; Zhang L; Wang E; Xu ML; Pan Z
    Am J Clin Pathol; 2019 Jul; 152(2):132-145. PubMed ID: 31140550
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular Pathogenesis of Mantle Cell Lymphoma.
    Navarro A; Beà S; Jares P; Campo E
    Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network.
    Aukema SM; Hoster E; Rosenwald A; Canoni D; Delfau-Larue MH; Rymkiewicz G; Thorns C; Hartmann S; Kluin-Nelemans H; Hermine O; Dreyling M; Klapper W
    Blood; 2018 Jan; 131(4):417-420. PubMed ID: 29196411
    [TBL] [Abstract][Full Text] [Related]  

  • 88. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
    Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
    Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cytarabine, Ki-67, and SOX11 in patients with mantle cell lymphoma receiving rituximab-containing autologous stem cell transplantation during first remission.
    Chakhachiro ZI; Saliba RM; Okoroji GJ; Korbling M; Alousi AM; Betul O; Anderlini P; Ciurea SO; Popat U; Champlin R; Samuels BI; Medeiros LJ; Bueso-Ramos C; Khouri IF
    Cancer; 2013 Sep; 119(18):3318-25. PubMed ID: 23775587
    [TBL] [Abstract][Full Text] [Related]  

  • 90. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
    Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
    Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [The Clinical-Biological Features and Prognosis of Patients with Mantle Cell Lymphoma].
    Chen WZ; Liu TB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1726-1732. PubMed ID: 38071052
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
    Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
    Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
    [TBL] [Abstract][Full Text] [Related]  

  • 93. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
    Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
    Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
    Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
    Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial.
    Bomben R; Ferrero S; D'Agaro T; Dal Bo M; Re A; Evangelista A; Carella AM; Zamò A; Vitolo U; Omedè P; Rusconi C; Arcaini L; Rigacci L; Luminari S; Piccin A; Liu D; Wiestner A; Gaidano G; Cortelazzo S; Ladetto M; Gattei V
    Haematologica; 2018 May; 103(5):849-856. PubMed ID: 29472356
    [TBL] [Abstract][Full Text] [Related]  

  • 96. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
    Hu Z; Sun Y; Schlette EJ; Tang G; Li S; Xu J; Yin CC; Young KH; Patel KP; Miranda RN; Goswami M; Wang M; Jorgensen JL; Medeiros LJ; Wang SA
    Mod Pathol; 2018 Feb; 31(2):327-336. PubMed ID: 28984300
    [TBL] [Abstract][Full Text] [Related]  

  • 97. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
    Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
    Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Expression of LATS mRNA in mantle cell lymphoma and its clinical significance].
    Yu Z; Yi S; Zhang Y; Li Z; Qiu L
    Zhonghua Yi Xue Za Zhi; 2015 Oct; 95(40):3285-8. PubMed ID: 26815349
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
    Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
    J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.
    Queirós AC; Beekman R; Vilarrasa-Blasi R; Duran-Ferrer M; Clot G; Merkel A; Raineri E; Russiñol N; Castellano G; Beà S; Navarro A; Kulis M; Verdaguer-Dot N; Jares P; Enjuanes A; Calasanz MJ; Bergmann A; Vater I; Salaverría I; van de Werken HJG; Wilson WH; Datta A; Flicek P; Royo R; Martens J; Giné E; Lopez-Guillermo A; Stunnenberg HG; Klapper W; Pott C; Heath S; Gut IG; Siebert R; Campo E; Martín-Subero JI
    Cancer Cell; 2016 Nov; 30(5):806-821. PubMed ID: 27846393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.